Vermillion & White Wealth Management Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-450
Closed -$1.88K 389
2025
Q4
$1.88K Hold
450
﹤0.01% 502
2025
Q3
$1.48K Hold
450
﹤0.01% 519
2025
Q2
$639 Hold
450
﹤0.01% 505
2025
Q1
$671 Hold
450
﹤0.01% 490
2024
Q4
$504 Hold
450
﹤0.01% 359
2024
Q3
$426 Hold
450
﹤0.01% 334
2024
Q2
$711 Hold
450
﹤0.01% 346
2024
Q1
$653 Sell
450
-450
-50% -$646 ﹤0.01% 324
2023
Q4
$1.21K Buy
+900
New +$1.06K ﹤0.01% 266

Other funds holding PGEN

Vermillion & White Wealth Management Group's PGEN Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Precigen (PGEN) in Q1 2026, closing a stake of 450 shares — an estimated $1.88K sold.

Vermillion & White Wealth Management Group first reported a position in PGEN in Q4 2023 and held it in 9 quarters. The position peaked at $1.88K in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 450 Precigen shares in Q1 2026, an estimated $1.88K.
  • Vermillion & White Wealth Management Group first reported a position in Precigen in Q4 2023 and held it in 9 quarters.
  • Vermillion & White Wealth Management Group's Precigen position peaked at $1.88K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.